Vir Biotechnology (VIR) Trades Higher in Sympathy with Janux Therapeutics (JANX)
Tweet
Share
E-mail
Get Alerts VIR Hot Sheet
Join SI Premium – FREE
Vir Biotechnology Inc. (NASDAQ: VIR) Trades Higher in Sympathy with Janux Therapeutics (NASDAQ: JANX)
- Janux Therapeutics Surges 40% After Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midera Food Processing and Centrus Energy to join S&P SmallCap 600
- JPMorgan Starts Kanzhun Ltd (2076:HK) at Overweight
- Aon plc (AON) files mixed shelf
Create E-mail Alert Related Categories
Corporate News, Momentum MoversRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
